Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BIRT 2584XX in moderate to severe plaque psoriasis
2005-005368-10Phase 2Terminated
- Sponsor
- Boehringer Ingelheim
- Start
- Mar 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of BIRT 2584 XX in plaque psoriasis (4 arms), sponsored by Boehringer Ingelheim. Primary endpoint: PASI75 at Week 12. Started Mar 2006; status: terminated.
02
Drugs
BIRT 2584 XX
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on 2005-005368-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005368-10.